Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Liraglutide in the Treatment of Type 1 Diabetes Mellitus

NCT01722266 is registered in ClinicalTrials.gov with University at Buffalo as lead sponsor.

NCT NCT01722266
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01722266 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Liraglutide in the Treatment of Type 1 Diabetes Mellitus
Lead sponsor
University at Buffalo
Phase
Phase 3
Overall status
Completed
Start date
November 1, 2012
Completion date
December 1, 2014
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes